WebAug 1, 2002 · Dingledine's group has identified a new class of compounds whose potency increases greatly as pH drops. “The idea is that this chemical wouldn't block the receptors … WebRay Dingledine's 9 research works with 75 citations and 352 reads, including: Phase 1 Clinical Results for NP10679, a pH‐sensitive GluN2B‐selective N‐methyl‐d‐aspartate …
Role of prostaglandin receptor EP2 in the regulations of cancer …
WebView Ray Dingledine’s professional profile on LinkedIn. LinkedIn is the world’s largest business network, helping professionals like Ray Dingledine discover inside connections … WebSep 6, 2024 · According to pharmacologist Ray Dingledine, good science is hard to do because of (1) "our drive to create a coherent narrative from new data, regardless of its quality or relevance"; (2) "our inclination to seek patterns in data whether they exist or not"; and (3) our negligence to "always consider how likely a result is regardless of its P-value." … cyst with internal septations
Department of Pharmacology and Chemical Biology Establishes …
WebExperimental evidence strongly indicates a significant role for inflammatory and immune mediators in initiation of seizures and epileptogenesis. Here we will summarize data … Raymond J Dingledine (born December 17, 1948) is an American pharmacologist and neurobiologist who has made considerable contributions to the field of epilepsy. He serves as Professor in the School of Medicine at Emory University, Atlanta GA, where he chaired the pharmacology department for 25 years and … See more Dingledine grew up in St. Marys, Ohio, a small town bordering Grand Lake St. Marys. He attended Michigan State University from 1967–1971 and graduated from Stanford University with a PhD in pharmacology in … See more Dingledine was elected to the US National Academy of Medicine in 2010, the Norwegian Academy of Science and Letters in 2024, and the National Academy of Inventors in … See more Selected papers • Kleckner, NW; Dingledine, R (12 August 1988). "Requirement for glycine in activation of NMDA … See more Dingledine joined the Department of Pharmacology at the University of North Carolina Chapel Hill in 1978 as an Assistant Professor, … See more His early research focused on the modulation of glutamate receptor-mediated synaptic transmission. During this period he and … See more Dingledine has two sons, Brian and Roger. Dingledine has grown bonsai trees since 1971 and for many years was an avid swimmer with a … See more WebPlease join me to congratulate Ray for this wonderful national recognition! Dr. Raymond J. Dingledine, professor and chair of the department of pharmacology at Emory University School of Medicine, is the recipient of … bindle icon